231 related articles for article (PubMed ID: 11159746)
1. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
Hulla JE; French JE; Dunnick JK
Carcinogenesis; 2001 Jan; 22(1):89-98. PubMed ID: 11159746
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein.
Hulla JE; French JE; Dunnick JK
Toxicol Sci; 2001 Apr; 60(2):264-70. PubMed ID: 11248138
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 11 loss from thymic lymphomas induced in heterozygous Trp53 mice by phenolphthalein.
Hulla JE
Toxicol Sci; 2001 Dec; 64(2):281-2. PubMed ID: 11719711
[No Abstract] [Full Text] [Related]
5. Loss of p53 in benzene-induced thymic lymphomas in p53+/- mice: evidence of chromosomal recombination.
Boley SE; Anderson EE; French JE; Donehower LA; Walker DB; Recio L
Cancer Res; 2000 Jun; 60(11):2831-5. PubMed ID: 10850423
[TBL] [Abstract][Full Text] [Related]
6. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice.
Dunnick JK; Hardisty JF; Herbert RA; Seely JC; Furedi-Machacek EM; Foley JF; Lacks GD; Stasiewicz S; French JE
Toxicol Pathol; 1997; 25(6):533-40. PubMed ID: 9437796
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
8. Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas.
Shimada Y; Nishimura M; Kakinuma S; Okumoto M; Shiroishi T; Clifton KH; Wakana S
Radiat Res; 2000 Sep; 154(3):293-300. PubMed ID: 10956435
[TBL] [Abstract][Full Text] [Related]
9. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
French J; Storer RD; Donehower LA
Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
[TBL] [Abstract][Full Text] [Related]
10. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
[TBL] [Abstract][Full Text] [Related]
11. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
[TBL] [Abstract][Full Text] [Related]
12. Motif-primed polymerase chain reaction-based allelotype of sarcomas induced by 3-methylcholanthrene in interspecific hybrid mice.
Dudley ME; Sundberg JP; Roopenian DC
Oncogene; 1995 Aug; 11(3):517-24. PubMed ID: 7630636
[TBL] [Abstract][Full Text] [Related]
13. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice.
Hegi ME; Söderkvist P; Foley JF; Schoonhoven R; Swenberg JA; Kari F; Maronpot R; Anderson MW; Wiseman RW
Carcinogenesis; 1993 May; 14(5):803-10. PubMed ID: 8504472
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cytotoxicity, cell proliferation, and genotoxicity induced by p-cresidine in hetero- and nullizygous transgenic p53 mice.
Delker DA; Yano BL; Gollapudi BB
Toxicol Sci; 2000 Jun; 55(2):361-9. PubMed ID: 10828268
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of recombinant chromosomes and low fidelity of transmission of chromosome X DNA markers in gamma-ray-induced lymphomas lacking p53.
Koide N; Matsumoto Y; Kosugi S; Chou D; Sakai K; Hatakeyama K; Niwa O; Kominami R
Mol Carcinog; 1999 Jan; 24(1):57-63. PubMed ID: 10029411
[TBL] [Abstract][Full Text] [Related]
16. Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.
Shetzer Y; Napchan Y; Kaufman T; Molchadsky A; Tal P; Goldfinger N; Rotter V
Int J Cancer; 2017 Mar; 140(6):1364-1369. PubMed ID: 28008605
[TBL] [Abstract][Full Text] [Related]
17. Phenolphthalein and bisacodyl: assessment of genotoxic and carcinogenic responses in heterozygous p53 (+/-) mice and syrian hamster embryo (SHE) assay.
Stoll RE; Blanchard KT; Stoltz JH; Majeska JB; Furst S; Lilly PD; Mennear JH
Toxicol Sci; 2006 Apr; 90(2):440-50. PubMed ID: 16373391
[TBL] [Abstract][Full Text] [Related]
18. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus.
French JE
IARC Sci Publ; 2004; (157):271-87. PubMed ID: 15055301
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice.
Hulla JE
Carcinogenesis; 2001 Nov; 22(11):1891. PubMed ID: 11698354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
